Skip Navigation
Skip to contents

Clin Endosc : Clinical Endoscopy

OPEN ACCESS

Search

Page Path
HOME > Search
7 "Endoscopic ultrasound-guided biliary drainage"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
Safety and efficacy of primary endoscopic ultrasound-guided hepaticogastrostomy in older patients: a retrospective study in Japan
Keigo Oshiro, Kazuo Hara, Nozomi Okuno, Shin Haba, Takamichi Kuwahara, Shimpei Matsumoto, Hiroki Koda, Tomoki Ogata, Saki Yamazoe, Tomoyuki Tanaka, Yuki Uba, Yuma Yamazaki
Received January 8, 2026  Accepted March 15, 2026  Published online October 14, 2026  
DOI: https://doi.org/10.5946/ce.2026.019    [Epub ahead of print]
Graphical AbstractGraphical Abstract AbstractAbstract PDF
Background
/Aims: Although endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) has been reported to have favorable outcomes, it is associated with a risk of severe adverse events. Despite the increasing frequency of EUS-HGS use in older patients, its safety and efficacy in this population have not been sufficiently evaluated.
Methods
We retrospectively analyzed 209 patients who underwent EUS-HGS for malignant distal biliary obstruction or Bismuth type I hilar biliary obstruction at our institution between April 2017 and October 2025. Patients were classified into an older group (group O, aged ≥75 years; n=54) or a non-older group (group non-O, aged <75 years; n=155). Patient characteristics and clinical outcomes were compared.
Results
The median age was 79 years (range, 75–91 years) in group O and 64 years (range, 33–74 years) in the non-O group. Serum creatinine levels (p=0.004) and the rate of antithrombotic agent use (p<0.001) were significantly higher in group O. No significant differences were observed regarding technical success rates (96.3% vs. 93.5%), clinical success rates (94.2% vs. 94.5%), or the incidence of early adverse events (≤14 days; 5.56% vs. 9.68%, p=0.57).
Conclusions
Our findings suggest that EUS-HGS is a feasible treatment option for older patients, achieving outcomes comparable to those of non-older patients.
  • 791 View
  • 11 Download
Close layer
Reviews
Endoscopic retrograde cholangiopancreatography versus endoscopic ultrasound-guided primary biliary drainage for malignant distal biliary obstruction: a review
Shawn Chun Sum Teoh, Anthony Yuen Bun Teoh
Clin Endosc 2026;59(5):726-731.   Published online September 14, 2026
DOI: https://doi.org/10.5946/ce.2026.122
AbstractAbstract PDF
Approximately 70% of pancreatic cancers arising in the head of the pancreas cause malignant distal biliary obstruction. Therefore, biliary drainage is an important aspect of the management of these patients. Conventionally, the technique for relieving biliary obstruction has been endoscopic retrograde cholangiopancreatography (ERCP). When ERCP cannot provide biliary drainage, such as in cases of failed cannulation, duodenal obstruction, or altered anatomy (e.g., after gastric bypass), endoscopic ultrasound-guided biliary drainage (EUS-BD) has been recommended by the American Society for Gastrointestinal Endoscopy as the preferred technique over percutaneous transhepatic biliary drainage for relieving biliary obstruction. Recently, EUS-BD has been explored as the primary technique for relieving biliary obstruction. The proposed benefits include higher technical success, shorter procedural time, a lower risk of pancreatitis, and longer stent patency. However, the results of randomized controlled studies have been conflicting. Hence, the aim of this article is to review the evidence from randomized controlled trials comparing EUS-BD with ERCP as the primary method of biliary drainage for malignant distal biliary obstruction.
  • 1,400 View
  • 96 Download
Close layer
Palliative endoscopic biliary drainage for malignant hilar biliary obstruction
Shuji Mitsuhashi, Manik Aggarwal, Vinay Chandrasekhara
Clin Endosc 2026;59(5):703-715.   Published online March 31, 2026
DOI: https://doi.org/10.5946/ce.2025.395
AbstractAbstract PDF
Malignant hilar biliary obstruction (MHBO) is most commonly caused by cholangiocarcinoma or gallbladder cancer and frequently presents with obstructive jaundice, pruritus, and/or cholangitis. These symptoms impair performance status and delay the initiation of chemotherapy, making biliary drainage essential for both palliation and oncologic treatment. Endoscopic transpapillary biliary stenting via endoscopic retrograde cholangiopancreatography is the standard approach for biliary decompression. In patients with unresectable disease, either plastic or self-expandable metal stents may be used. Optimal outcomes are achieved when drainage encompasses more than 50% of functional liver volume, while atrophic segments should be avoided. When transpapillary access is not feasible or unsuccessful, alternative approaches such as percutaneous transhepatic biliary drainage or endoscopic ultrasound-guided biliary drainage may be considered. Adjunctive therapies, including photodynamic therapy and radiofrequency ablation, are being investigated to enhance local tumor control and prolong stent patency. With continued advances in stent technology, imaging modalities, and endoscopic techniques, the management of MHBO is expected to become increasingly individualized and effective.
  • 5,420 View
  • 400 Download
Close layer
Systematic Review and Meta-analysis
Efficacy of endoscopic ultrasound-guided biliary drainage of malignant biliary obstruction: a systematic review and meta-analysis of randomized controlled trials
Yousaf Zafar, Hafsa Azam, Muhammad Abdullah Bin Azhar, Fabeeha Shaheen, Syed Sarmad Javaid, Laila Manzoor, Muaaz Masood, Rajesh Krishnamoorthi
Clin Endosc 2025;58(4):533-543.   Published online February 24, 2025
DOI: https://doi.org/10.5946/ce.2024.183
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary Material
Background
/Aims: Malignant biliary obstruction is a major clinical challenge. We assessed the efficacy of endoscopic ultrasound-guided biliary drainage (EUS-BD) compared with that of endoscopic retrograde cholangiopancreatography biliary drainage (ERCP-BD) or percutaneous transhepatic biliary drainage (PTBD).
Methods
We searched for randomized controlled trials comparing EUS-BD with ERCP or PTBD in treating malignant biliary obstruction. Using random-effects models, we synthesized risk ratios (RRs) and weighted mean differences (WMDs) with 95% confidence intervals (CIs). A subgroup analysis was performed using a comparator (ERCP or PTBD).
Results
EUS-BD significantly reduced the risk of stent dysfunction (RR, 0.46; 95% CI, 0.33–0.64), with consistent results in subgroup analysis for ERCP (RR, 0.54; 95% CI, 0.35–0.84) and PTBD (RR, 0.37; 95% CI, 0.22–0.61). It also lowered the risk of post-procedure pancreatitis (RR, 0.24; 95% CI, 0.07–0.83) and reduced tumor ingrowth or overgrowth risk (RR, 0.27; 95% CI, 0.11–0.65), even when compared to ERCP alone (RR, 0.28; 95% CI, 0.11–0.70). EUS-BD demonstrated a lower risk of adverse events compared to PTBD (RR, 0.37; 95% CI, 0.14–0.97) and reduced length of hospital stay (WMD, –1.03; 95% CI, –1.53 to –0.53) when compared to ERCP.
Conclusions
EUS-BD outperformed ERCP-BD and PTBD in reducing stent dysfunction, postprocedural pancreatitis, and tumor ingrowth or overgrowth.

Citations

Citations to this article as recorded by  
  • Reply
    Joan B. Gornals, Albert Sumalla-Garcia, Carme Loras
    Clinical Gastroenterology and Hepatology.2026; 24(4): 1203.     CrossRef
  • Biliary Drainage in Altered Anatomy: A Comprehensive Literature Review
    Rishi Chowdhary, Jorge D. Machicado, Veeral M. Oza
    Journal of Digestive Endoscopy.2026;[Epub]     CrossRef
  • A Time-Based and Clinical Status Stratified Protocol for Major Bile Duct Injury After Cholecystectomy: Retrospective, Single-Center Outcomes From a Resource-Limited Setting
    Ahmed Ateik, Saif A Ghabisha, Lamia Abdulmughni, Fares Awn
    Cureus.2026;[Epub]     CrossRef
  • Biliary Drainage During Neoadjuvant Chemotherapy in Pancreatic Cancer: Evidence and Practical Recommendations
    Tadahisa Inoue, Masanao Nakamura, Kiyoaki Ito
    Cancers.2026; 18(3): 467.     CrossRef
  • Endoscopic Ultrasound-Guided Versus Percutaneous Transhepatic Biliary Drainage After Failed Endoscopic Retrograde Cholangiopancreatography in Malignant Biliary Obstruction: A Single-Center Retrospective Cohort
    Wojciech Ciesielski, Łukasz Durko, Ludomir Stefańczyk, Adam Dobek, Anna Bulicz, Amelia Wojnicka, Zuzanna Sosnowska, Agata Grochowska, Janusz Strzelczyk, Piotr Hogendorf, Adam Durczyński, Tomasz Klimczak
    Cancers.2026; 18(5): 783.     CrossRef
  • Role of Endoscopy in Malignant Biliary Obstruction
    Ishaan Vohra, Burraq Imran, Zubair Khan, Muhammad Hasan
    Diagnostics.2026; 16(5): 721.     CrossRef
  • Case Report: Unexpected LAMS obstruction following successful EUS-BD in a patient with pancreatic carcinoma
    Xuxia He, Kun He, Qiang Wang
    Frontiers in Surgery.2026;[Epub]     CrossRef
  • EUS-guided biliary drainage versus percutaneous transhepatic biliary drainage after failed ERCP in oncological patients: a 10-year retrospective comparison
    P Alves, L Lenz, C Clemente, I Kristal, M Beltrami, AD P Gustavo, B Costa Martins, A Safatle-Ribeiro, F Maluf-Filho
    Endoscopy.2026; 58(S 03): S634.     CrossRef
  • Endoscopic Ultrasound-Guided Choledochoduodenostomy With Lumen-Apposing Metal Stents: Here to Stay, But All That Glitters Is Not Gold
    Joan B. Gornals, Manuel Perez-Miranda, Carme Loras
    Gastroenterology.2026; 171(3): 568.     CrossRef
  • 11,420 View
  • 472 Download
  • 8 Web of Science
  • 9 Crossref
Close layer
Review
Endoscopic biliary drainage for distal bile duct obstruction due to pancreatic cancer
Masahiro Itonaga, Masayuki Kitano
Clin Endosc 2025;58(1):40-52.   Published online September 26, 2024
DOI: https://doi.org/10.5946/ce.2023.294
AbstractAbstract PDF
Approximately 60% of pancreatic cancers occur in the pancreatic head and may present as obstructive jaundice due to bile duct invasion. Obstructive jaundice often leads to poor general conditions and acute cholangitis, interfering with surgery and chemotherapy and requiring biliary drainage. The first choice of treatment for biliary drainage is the endoscopic transpapillary approach. In unresectable tumors, self-expandable metal stents (SEMSs) are most commonly used and are classified into uncovered and covered SEMSs. Recently, antireflux metal stents and large- or small-diameter SEMSs have become commercially available, and their usefulness has been reported. Plastic stents are infrequently used in patients with resectable biliary obstruction; however, owing to the recent trend in preoperative chemotherapy, SEMSs are frequently used because of the long time to recurrent biliary obstruction. Endoscopic ultrasound-guided biliary drainage (EUS-BD) is often performed in patients who are not eligible for the transpapillary approach, and favorable outcomes have been reported. Different EUS-BD techniques and specialized stents have been developed and can be safely used in high-volume centers. The indications for EUS-BD are expected to further expand in the future.

Citations

Citations to this article as recorded by  
  • Comparative Evaluation of Percutaneous Transhepatic Biliary Drainage and Endoscopic Ultrasound‐Guided Biliary Drainage for Preoperative Management of Malignant Distal Bile Duct Obstruction After Failed ERCP: A Multicenter Retrospective Analysis
    Masahiro Itonaga, Mamoru Takenaka, Hideyuki Shiomi, Koh Kitagawa, Shuhei Shintani, Hirotsugu Maruyama, Ryota Sagami, Tsukasa Ikeura, Takeshi Ogura, Yusuke Ishida, Koichiro Mandai, Satoshi Sugimori, Yoshiki Imamura, Atsuhiro Masuda, Kenji Ikezawa, Atsushi
    Digestive Endoscopy.2026;[Epub]     CrossRef
  • Adverse Events of EUS‐Guided Biliary Drainage for Malignant Biliary Obstruction: A Large Multicenter Study
    Masahiro Itonaga, Takeshi Ogura, Mamoru Takenaka, Kazuyuki Matsumoto, Hideyuki Shiomi, Shuhei Shintani, Hideki Kamada, Taro Yamashita, Koichiro Mandai, Masanori Asada, Hajime Imai, Kotaro Takeshita, Tsukasa Ikeura, Nao Fujimori, Makiko Kinoshita, Kenji Ik
    Journal of Hepato-Biliary-Pancreatic Sciences.2026; 33(3): 228.     CrossRef
  • Mechanistic insights into pancreatic cancer progression from circadian rhythm disruption and gut microbiota dysbiosis (Review)
    Yang Liu, Yongfeng Li, Heng Ma, Shichang Deng, Chao Cheng
    International Journal of Molecular Medicine.2026; 57(3): 1.     CrossRef
  • Partially covered or uncovered metal stent efficacy in malignant unresectable distal biliary obstruction (METARSI): Randomized multicenter trial
    Silvia Cocca, Flavia Pigò, Helga Bertani, Roberta Rea, Giuseppina Pontillo, Michele Campigotto, Giuseppe Grande, Salvatore Russo, Margherita Marocchi, Marinella Lupo, Gian Maria Prati, Giovanni Aragona, Raffaele Manta, Carmelo Barbera, Fabio Monica, Franc
    Endoscopy International Open.2026;[Epub]     CrossRef
  • Comparison of approaches: multiple plastic versus single plastic biliary stenting
    E.N. Solodinina, N.S. Politov
    Russian Journal of Evidence-Based Gastroenterology.2026; 15(1): 37.     CrossRef
  • Beyond cylindrical stents: does a tapered-and-flared design improve biliary drainage?
    Woo Hyun Paik
    Clinical Endoscopy.2026; 59(3): 406.     CrossRef
  • Latest advancements in endoscopic palliative care for patients with pancreatic cancer
    Raquel Gonçalves, Joel Silva, Eduardo Rodrigues-Pinto
    Clinical Endoscopy.2026; 59(4): 497.     CrossRef
  • Endoscopic Ultrasound-Guided Gallbladder Drainage Using Double-Pigtail Plastic Stents for Acute Cholecystitis in Patients with Malignant Biliary Obstruction
    Keiki Nagai, Yusuke Kurita, Yuji Fujita, Kensuke Kubota, Tomoki Ogata, Etsuko Yamabe, Hiroki Uechi, Yuji Koyama, Shintaro Tsujikawa, Yu Honda, Takayuki Oda, Takeshi Iizuka, Shin Yagi, Eisuke Suzuki, Seitaro Tsujino, Ken Ishii, Sho Hasegawa, Shingo Kato, M
    Journal of Clinical Medicine.2026; 15(16): 6329.     CrossRef
  • Malignant Double Obstruction: How Can Advanced Endoscopy Help?
    Alessandro De Marco, Marco Spadaccini, Gianluca Franchellucci, Matteo Colombo, Miriana Mercurio, Maddalena Menini, Marta Andreozzi, Maria Terrin, Valeria Poletti, Anita Busacca, Francesco Minini, Simone Segato, Marco Balzarini, Silvia Carrara, Alessandro
    Medicina.2026; 62(9): 1678.     CrossRef
  • Endoscopic Ultrasound‐Guided Hepaticogastrostomy With Plastic Stent Versus Metallic Stent for Malignant Biliary Obstruction: A Meta‐Analysis
    Hirofumi Yamazaki, Masahiro Itonaga, Ke Wan, Yasunobu Yamashita, Reiko Ashida, Masayuki Kitano
    Digestive Endoscopy.2026;[Epub]     CrossRef
  • Balloon Enteroscopy‐Assisted ERCP and EUS‐Guided Biliary Drainage for Malignant Biliary Obstruction in Patients With Surgically Altered Anatomy: A Systematic Review and Meta‐Analysis
    Masahiro Itonaga, Ke Wan, Tamura Takashi, Yasunobu Yamashita, Reiko Ashida, Masayuki Kitano
    Digestive Endoscopy.2026;[Epub]     CrossRef
  • Balloon Enteroscopy‐Assisted ERCP Versus Endoscopic Ultrasound‐Guided Biliary Drainage for Unresectable Malignant Biliary Obstruction in Patients With Surgically Altered Anatomy: A Multicenter Prospective Registration Study
    Masahiro Itonaga, Mamoru Takenaka, Kenji Ikezawa, Tsukasa Ikeura, Masaaki Shimatani, Masanori Asada, Nao Fujimori, Ryota Sagami, Takeshi Ogura, Hajime Imai, Kazuyuki Matsumoto, Shuhei Shintani, Hideyuki Shiomi, Keiichi Hatamaru, Kosuke Minaga, Ryoji Takad
    Digestive Endoscopy.2025; 37(11): 1179.     CrossRef
  • Advances in Endoscopic Management of Distal Biliary Stricture: Integrating Clinical Evidence into Patient-Specific Decision-Making
    Reiko Yamada, Tetsuro Miwata, Yoshifumi Nakamura, Kenji Nose, Takamitsu Tanaka, Hirono Owa, Minako Urata, Yasuaki Shimada, Hayato Nakagawa
    Cancers.2025; 17(16): 2644.     CrossRef
  • Successful conversion of percutaneous transhepatic gallbladder drainage to endoscopic ultrasound-guided hepaticogastrostomy combined with antegrade stenting for a malignant distal biliary obstruction due to invasive intraductal papillary mucinous carcinom
    Taiji Yoshimoto, Takeshi Takajo, Hiroshi Takihara, Ryuichi Yamamoto
    Journal of Medical Case Reports.2025;[Epub]     CrossRef
  • 14,981 View
  • 464 Download
  • 13 Web of Science
  • 14 Crossref
Close layer
Original Articles
Hepatobiliary scintigraphy of bile excretion after endoscopic ultrasound-guided hepaticogastrostomy for malignant biliary obstruction: a retrospective study in Japan
Masanori Yamada, Kazuo Hara, Shin Haba, Takamichi Kuwahara, Nozomi Okuno, Yasuhiro Kuraishi, Takafumi Yanaidani, Sho Ishikawa, Tsukasa Yasuda, Toshitaka Fukui
Clin Endosc 2024;57(6):798-806.   Published online August 20, 2024
DOI: https://doi.org/10.5946/ce.2023.291
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary Material
Background
/Aims: Hepatobiliary scintigraphy (HBS) is used to evaluate bile excretion. This study aimed to evaluate biliary excretion during endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) using HBS.
Methods
We retrospectively evaluated 78 consecutive patients with malignant extrahepatic biliary obstruction, who underwent HBS after EUS-HGS between April 2015 and July 2022. The peak time and decay rate were scored with 0, 1, or 2 points based on thresholds of 20 and 35 minutes, and 10% and 50%, respectively. A total score of 4 or 3 was considered indicative of good bile excretion, whereas scores of 2, 1, or 0 indicated poor bile excretion.
Results
The good and poor bile excretion groups included 40 and 38 cases, respectively. The group with good bile excretion had a significantly longer time to recurrent biliary obstruction compared to the poor bile excretion group (not reached vs. 124 days, p=0.026). Multivariate analysis identified the site of obstruction as a significant factor influencing good bile excretion (odds ratio, 3.39; 95% confidence interval, 1.01–11.4, p=0.049), with superior bile excretion observed in cases involving upper biliary obstruction compared to middle or lower biliary obstruction.
Conclusions
In patients with malignant biliary obstruction who underwent HGS, the site of obstruction is significantly associated with stent patency.

Citations

Citations to this article as recorded by  
  • Endoscopic ultrasound-guided transpapillary versus transluminal biliary stenting: randomized comparison of long-term stent patency
    Vinay Dhir, Vivek Kumar Singh, Sundeep Lakhtakia, Rajesh Puri, Praveer Rai, Nonthalee Pausawasdi, Ryosuke Tonozuka, Jahangeer Basha, Varayu Prachayakul, Abhishek Kathuria, Pankaj Kumar, Takao Itoi, D. Nageshwar Reddy
    Endoscopy.2026; 58(05): 493.     CrossRef
  • Distinguishing the mechanisms of recurrent biliary obstruction among antegrade transpapillary stenting versus hepaticogastrostomy versus choledochoduodenostomy
    Rungsun Rerknimitr
    Endoscopy.2026; 58(09): 1061.     CrossRef
  • Reply to Prof. Rerknimitr
    Vinay Dhir, Vivek Kumar Singh
    Endoscopy.2026; 58(09): 1062.     CrossRef
  • 6,107 View
  • 215 Download
  • 3 Web of Science
  • 3 Crossref
Close layer
Role of interventional endoscopic ultrasound in a developing country
Hasan Maulahela, Nagita Gianty Annisa, Achmad Fauzi, Kaka Renaldi, Murdani Abdullah, Marcellus Simadibrata, Dadang Makmun, Ari Fahrial Syam
Clin Endosc 2023;56(1):100-106.   Published online January 17, 2023
DOI: https://doi.org/10.5946/ce.2022.058
AbstractAbstract PDF
Background
/Aims: Endoscopic ultrasound (EUS) has become an essential diagnostic and therapeutic tool. EUS was introduced in 2013 in Indonesia and is considered relatively new. This study aimed to describe the current role of interventional EUS at our hospital as a part of the Indonesian tertiary health center experience.
Methods
This retrospective study included all patients who underwent interventional EUS (n=94) at our center between January 2015 and December 2020. Patient characteristics, technical success, clinical success, and adverse events associated with each type of interventional EUS procedure were evaluated.
Results
Altogether, 94 interventional EUS procedures were performed at our center between 2015 and 2020 including 75 cases of EUS-guided biliary drainage (EUS-BD), 14 cases of EUS-guided pancreatic fluid drainage, and five cases of EUS-guided celiac plexus neurolysis. The technical and clinical success rates of EUS-BD were 98.6% and 52%, respectively. The technical success rate was 100% for both EUS-guided pancreatic fluid drainage and EUS-guided celiac plexus neurolysis. The adverse event rates were 10.6% and 7.1% for EUS-BD and EUS-guided pancreatic fluid drainage, respectively.
Conclusions
EUS is an effective and safe tool for the treatment of gastrointestinal and biliary diseases. It has a low rate of adverse events, even in developing countries.

Citations

Citations to this article as recorded by  
  • EUS-guided interventional therapies for pancreatic diseases
    Rongmin Xu, Kai Zhang, Nan Ge, Siyu Sun
    Frontiers in Medicine.2024;[Epub]     CrossRef
  • 6,611 View
  • 187 Download
  • 1 Web of Science
  • 1 Crossref
Close layer

Clin Endosc : Clinical Endoscopy Twitter Facebook
Close layer
TOP